Findings from the researchers’ study of the safety and efficacy of the vaccine were published this week in a peer-reviewed journal. Phase 2 trials are underway.
Building on McMaster’s decades of leadership in vaccinology, the event brought together hundreds of researchers, officials, industry leaders and community partners.
In celebration of World Immunization Week, McMaster is proud to highlight our storied legacy in vaccine research, development, and innovation spanning over 50 years.
McMaster logo
McMaster logo
